Literature DB >> 20424239

Questionable antipsychotic prescribing remains common, despite serious risks.

Bridget M Kuehn.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20424239     DOI： 10.1001/jama.2010.453

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors:  Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal:  Eur J Clin Pharmacol       Date:  2011-12-04       Impact factor: 2.953

2.  Off-label use of atypical antipsychotics: cause for concern?

Authors:  Andrew McKean; Erik Monasterio
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 3.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

4.  Prenatal antipsychotic exposure and neuromotor performance during infancy.

Authors:  Katrina C Johnson; Jamie L LaPrairie; Patricia A Brennan; Zachary N Stowe; D Jeffrey Newport
Journal:  Arch Gen Psychiatry       Date:  2012-08

Review 5.  Use of atypical antipsychotics in the elderly: a clinical review.

Authors:  Pietro Gareri; Cristina Segura-García; Valeria Graziella Laura Manfredi; Antonella Bruni; Paola Ciambrone; Gregorio Cerminara; Giovambattista De Sarro; Pasquale De Fazio
Journal:  Clin Interv Aging       Date:  2014-08-16       Impact factor: 4.458

6.  The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians.

Authors:  Martina Kelly; Tim Dornan; Tamara Pringsheim
Journal:  CMAJ Open       Date:  2018-04-30

7.  Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults.

Authors:  Marcela Horvitz-Lennon; Rita Volya; Simon Hollands; Katya Zelevinsky; Andrew Mulcahy; Julie M Donohue; Sharon-Lise T Normand
Journal:  Psychiatr Serv       Date:  2021-06-02       Impact factor: 4.157

Review 8.  Etiology of cardiovascular disease in patients with schizophrenia: current perspectives.

Authors:  Murat Emul; Tevfik Kalelioglu
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-01       Impact factor: 2.570

9.  Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

Authors:  Gloria M Reeves; Courtney Keeton; Christoph U Correll; Jacqueline L Johnson; Robert M Hamer; Linmarie Sikich; Lindsey Hazzard; Cheryl Alderman; Abigail Scheer; Micah Mabe; Sandeep Kapoor; Eva Sheridan; Irmgard Borner; Kristin Bussell; Sara Pirmohamed; Terrence C Bethea; Raja Chekuri; Rhoda Gottfried; Shauna P Reinblatt; Erin Santana; Mark A Riddle
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2013-08-15       Impact factor: 3.033
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.